Publications by authors named "Mitchell Sabloff"

Claim this Profile
R
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.
Tracy Murphy, Boyang Zhang, Tong Zhang, Ian King, Jose-Mario Capo-Chichi, Mitchell Sabloff

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML.
Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Mitchell Sabloff

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Tumour Lysis Syndrome in Patients with Acute Myeloid Leukemia During Initiation of Therapy with Azacitidine and Venetoclax: A Retrospective Chart Review from a Canadian Single-Centre Perspective.
Tana Saiyin, Grace Christou, Mitchell Sabloff, Tina Crosbie, Kim-My Nguyen-Tham

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and Healthcare Professional Reflections on Consenting for Extra Bone Marrow Samples to a Biobank for Research-A Qualitative Study.
Stuart G Nicholls, Erika Camilleri, Taryn Chesser, Gary Davis, Katya Godard, Mitchell Sabloff

Curr Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in quality of life in MDS patients who become transfusion independent after treatment.
Bo A Wan, Shabbir M H Alibhai, Lisa Chodirker, Lee Mozessohn, Michelle Geddes, Mitchell Sabloff

Leuk Lymphoma· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III SIERRA Trial of I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow, Mitchell Sabloff

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.
Mats Brune, Thomas Kiss, Harald Anderson, Malin Nicklasson, Robert Delage, Mitchell Sabloff

Bone Marrow Transplant· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Organizational Requirements to Standardize Delivery and Improve Quality of Acute Leukemia Care in Ontario.
Leslie Verville, Cassandra McKay, Tom Kouroukis, Suzanna Apostolovski, Mitchell Sabloff

Curr Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan, Mitchell Sabloff

Lancet Haematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, Christopher Bredeson, Mitchell Sabloff

Transplant Cell Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.
Muhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, Karen Chen, David Allan, Mitchell Sabloff

Transplant Cell Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes.
Lee Mozessohn, Qing Li, Ning Liu, Brian Leber, Dina Khalaf, Mitchell Sabloff

JCO Oncol Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes.
Jennifer Teichman, Michelle Geddes, Nancy Zhu, Mary-Margaret Keating, Mitchell Sabloff

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis.
Aidan M Kirkham, Adrian J M Bailey, Ashish Masurekar, Risa Shorr, Christopher Bredeson, Mitchell Sabloff

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes.
Eugene Brailovski, Qing Li, Ning Liu, Brian Leber, Dina Khalaf, Mitchell Sabloff

Ann Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study.
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Mitchell Sabloff

Transplantation· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Mitchell Sabloff

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
Jill Fulcher, Philip Berardi, Grace Christou, Pierre J A Villeneuve, Christopher Bredeson, Mitchell Sabloff

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Asmita Mishra, Jaime M Preussler, Vijaya Raj Bhatt, Christopher Bredeson, Saurabh Chhabra, Mitchell Sabloff

Transplant Cell Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.
Irina Amitai, Michelle Geddes, Nancy Zhu, Mary-Margaret Keating, Mitchell Sabloff

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?
Mitchell Sabloff, Steven Tisseverasinghe, Mustafa Ege Babadagli, Rajiv Samant

Curr Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revised 15-item MDS-specific frailty scale maintains prognostic potential.
Bo A Wan, Aziz Nazha, Rebecca Starkman, Shabbir Alibhai, Richard A Wells, Mitchell Sabloff

Leukemia· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Aziz Nazha, Zhen-Huan Hu, Tao Wang, R Coleman Lindsley, Hisham Abdel-Azim, Mitchell Sabloff

Biol Blood Marrow Transplant· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies.
Harinad Maganti, Alissa Visram, Risa Shorr, Jill Fulcher, Mitchell Sabloff

Leuk Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia.
Jill Fulcher, Eugene Leung, Grace Christou, Christopher Bredeson, Mitchell Sabloff

Leuk Lymphoma· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis